Cargando…
Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?
Alzheimer’s disease (AD) is the most common age-related neurodegenerative disorder characterized by cognitive decline and by the presence of amyloid β plaques and neurofibrillary tangles in the brain. Despite recent advances in understanding its pathophysiological mechanisms, to date, there are no d...
Autores principales: | Munafò, Antonio, Burgaletto, Chiara, Di Benedetto, Giulia, Di Mauro, Marco, Di Mauro, Rosaria, Bernardini, Renato, Cantarella, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746859/ https://www.ncbi.nlm.nih.gov/pubmed/33343293 http://dx.doi.org/10.3389/fnins.2020.614643 |
Ejemplares similares
-
The immune system on the TRAIL of Alzheimer’s disease
por: Burgaletto, Chiara, et al.
Publicado: (2020) -
Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca(2+) Homeostasis Dysregulation
por: Di Benedetto, Giulia, et al.
Publicado: (2022) -
TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β
por: Di Benedetto, Giulia, et al.
Publicado: (2022) -
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine
por: Munafò, Antonio, et al.
Publicado: (2021) -
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease
por: Burgaletto, Chiara, et al.
Publicado: (2021)